THE SILENT PANDEMIC: A SYSTEMATIC REVIEW OF THE GLOBAL DIABETES BURDEN AND THE EMERGING CRISIS IN UZBEKISTAN
Keywords:
diabetes mellitus, global burden, Uzbekistan, Central Asia, epidemiology, systematic review, non communicable diseasesAbstract
Diabetes mellitus has become one of the defining public health problems of the 21st century. It now reaches almost every part of the world and falls hardest on low- and middle-income countries. This systematic review draws together current evidence on the global burden of diabetes and then looks closely at Uzbekistan, a Central Asian country moving quickly through an epidemiological transition. Using data from the International Diabetes Federation (IDF) Diabetes Atlas, Global Burden of Disease (GBD) studies, and national surveys, we examined the prevalence, incidence, mortality, and economic dimensions of the disease. Around 589 million adults aged 20 to 79 years were living with diabetes worldwide in 2024, and that number is projected to reach 853 million by 2050. Central Asia is growing fastest among the Asian subregions, with an average annual percent change in prevalence of 2.73%. In Uzbekistan, prevalence among adults aged 20 to 79 years stood at 7.5% in 2024, affecting roughly 1.5 million people, and is expected to rise to 2.2 million by 2050. The real figure is thought to be about ten times higher than registry-based data suggest, with 74% of cases remaining undiagnosed. Type 1 diabetes among children and adolescents has quadrupled over the past 24 years. The economic toll is heavy, with global macroeconomic losses projected to exceed 10 trillion USD by 2050. Together these findings point to an urgent need for stronger surveillance, early detection programmes, and focused public health action in Uzbekistan and across the wider Central Asian region.
References
1.International Diabetes Federation. IDF Diabetes Atlas (11th Edition). Brussels: IDF; 2025.
2.Ong KL, Stafford LK, McLaughlin SA, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203–234.
3.Alieva AV, Ismailov SI, Rakhimova GN. Epidemiology of diabetes mellitus and prediabetes in Uzbekistan. Tashkent: Republican Center of Endocrinology; 2016.
4.Alimov AV, Alimova NU, Alieva AV, et al. Comparative analysis of key epidemiological indicators of type 1 diabetes in children and adolescents in the Republic of Uzbekistan from 2000 to 2024. Proceedings of the Turakulov Readings 2025 Conference. Atlantis Press; 2025. doi:10.2991/978-94-6463-984-1_12.
5.Chen S, et al. The global macroeconomic burden of diabetes mellitus. Nat Med. 2025; doi:10.1038/s41591-025-04027-5.
6.Ahmad E, Lim S, Lamptey R, et al. Type 2 diabetes. Lancet. 2022;400(10365):1803–1820.
7.Elmusharaf K, et al. A cost of illness study of the economic burden of diabetes in the Eastern Mediterranean Region. East Mediterr Health J. 2025;31(7):426–435.
8.Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34(6):1249–1257.
9.King H, et al. Epidemiology of glucose intolerance and associated factors in Uzbekistan: a survey in Sirdaria province. Diabetes Res Clin Pract. 2002;55(1):35–43.
10.Yu X, et al. Global epidemiology and burden of type 2 diabetes in adults: trends, projections, and implications. Ther Adv Chronic Dis. 2025;16:20420188251362011.
11.World Health Organization. WHO STEPS Noncommunicable Disease Risk Factor Surveillance: Uzbekistan 2014. Geneva: WHO; 2014.
12.Ye J, et al. The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019. Front Endocrinol. 2023;14:1192629.
13.Zhu W, et al. Burden of type 2 diabetes in Asia Pacific regions, 1990 to 2021: GBD 2021 analysis with forecast to 2050. Diabet Med. 2026;Apr. doi:10.1111/dme.70216.
14.Ali MK, Pearson Stuttard J, Selvin E, Gregg EW. Interpreting global trends in type 2 diabetes complications and mortality. Diabetologia. 2022;65(1):3–13.
15.Alieva AV, et al. Epidemiology of diabetes and prediabetes in Uzbekistan: screening results. J Theor Clin Med. 2018; doi:10.4172/2167-0943.100064.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal